{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:57:04Z","timestamp":1761843424914},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.idc.2005.03.007","type":"journal-article","created":{"date-parts":[[2005,6,20]],"date-time":"2005-06-20T20:04:24Z","timestamp":1119297864000},"page":"477-490","source":"Crossref","is-referenced-by-count":17,"title":["Progress in Vaccines for Sexually Transmitted Diseases"],"prefix":"10.1016","volume":"19","author":[{"given":"Lawrence R.","family":"Stanberry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2005.03.007_bib1","series-title":"Sexually transmitted disease: vaccines, prevention and control","first-page":"339","article-title":"Chlamydia","author":"Brunham","year":"2000"},{"key":"10.1016\/j.idc.2005.03.007_bib2","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1099\/00221287-139-12-2965","article-title":"Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis","volume":"139","author":"Batteiger","year":"1993","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.idc.2005.03.007_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/377134","article-title":"Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens","volume":"188","author":"Moore","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib4","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.173.5.3375","article-title":"A novel recombinant multisubunit vaccine against Chlamydia","volume":"173","author":"Eko","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.idc.2005.03.007_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1099\/jmm.0.05442-0","article-title":"Molecular cloning of the Chlamydophila abortus groEL gene and evaluation of its protective efficacy in a murine model by genetic vaccination","volume":"53","author":"Hechard","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.idc.2005.03.007_bib6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/516545","article-title":"DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection","volume":"176","author":"Zhang","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib7","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.171.9.4742","article-title":"An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+T cell response","volume":"171","author":"Starnbach","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.idc.2005.03.007_bib8","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1016\/S0264-410X(01)00117-7","article-title":"The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis","volume":"19","author":"Whittum-Hudson","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2005.03.007_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-0378(00)00069-3","article-title":"Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development","volume":"48","author":"Beagley","year":"2000","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.idc.2005.03.007_bib10","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1128\/IAI.67.10.5486-5489.1999","article-title":"Expression of Chlamydia psittaci- and human immunodeficiency virus-derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusions to bspA","volume":"67","author":"Turner","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.idc.2005.03.007_bib11","series-title":"Sexually transmitted disease: vaccines, prevention and control","first-page":"369","article-title":"Gonorrhea: epidemiology, control and prevention","author":"Zenilman","year":"2000"},{"key":"10.1016\/j.idc.2005.03.007_bib12","series-title":"Bacterial vaccines","first-page":"127","article-title":"A vaccine for gonorrhea","author":"Sparling","year":"2003"},{"key":"10.1016\/j.idc.2005.03.007_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00007435-200110000-00001","article-title":"Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers","volume":"28","author":"Schmidt","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/374563","article-title":"Porin variation among clinical isolates of Neisseria gonorrhoeae over a 10-year period, as determined by Por variable region typing","volume":"187","author":"McKnew","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib15","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.164.5.1735","article-title":"Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum","volume":"164","author":"Rice","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.idc.2005.03.007_bib16","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/IAI.68.9.4938-4947.2000","article-title":"Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine","volume":"68","author":"Rokbi","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.idc.2005.03.007_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/08830180109043036","article-title":"Strategies for mimicking Neisserial saccharide epitopes as vaccines","volume":"20","author":"Gulati","year":"2001","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.idc.2005.03.007_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.vaccine.2003.08.036","article-title":"DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment","volume":"22","author":"Zhu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2005.03.007_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","article-title":"The theoretical population-level impact of a prophylactic human papilloma virus vaccine","volume":"13","author":"Hughes","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.idc.2005.03.007_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1783\/0000000042177162","article-title":"Human papillomavirus (HPV) vaccines: prospects for eradicating cervical cancer","volume":"30","author":"Stanley","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.idc.2005.03.007_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0301-2115(03)00093-9","article-title":"Cervical response to vaccination against HPV16 E7 in case of severe dysplasia","volume":"109","author":"Simon","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.idc.2005.03.007_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00262-004-0501-4","article-title":"Phase I\/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia","volume":"53","author":"Hallez","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.idc.2005.03.007_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/10430340460745757","article-title":"Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus","volume":"5","author":"Corona Gutierrez","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.idc.2005.03.007_bib24","first-page":"6032","article-title":"Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16\/18 oncoproteins","volume":"63","author":"Davidson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.idc.2005.03.007_bib25","first-page":"5205","article-title":"Vaccinia-expressed human papillomavirus 16 and 18 E6 and E7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia","volume":"9","author":"Baldwin","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.idc.2005.03.007_bib26","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1078-0432.CCR-03-0703","article-title":"Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination","volume":"10","author":"Smyth","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.idc.2005.03.007_bib27","unstructured":"Stressgen Biotechnologies. Stressgen announces positive phase II data in high grade cervical dysplasia. Available at: http:\/\/www.stressgen.com. Accessed December 4, 2004."},{"key":"10.1016\/j.idc.2005.03.007_bib28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00432-003-0463-5","article-title":"Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients","volume":"129","author":"Ferrara","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.idc.2005.03.007_bib29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001622-200409000-00013","article-title":"Vaccination strategies for the treatment and prevention of cervical cancer","volume":"16","author":"Schreckenberger","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.idc.2005.03.007_bib30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/314616","article-title":"Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts","volume":"179","author":"Lacey","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib31","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2005.03.007_bib32","unstructured":"Mao C, Koutsky L, Ault K, et al. Prophylactic human papillomavirus (HPV) 16 virus-like particle (VLP) vaccine prevents HPV16-related cervical intraepithelial neoplasia (CIN) 2\u20133 [abstract G-3741]. In: Programs and abstracts from the 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington (DC): 2004. p. 72."},{"key":"10.1016\/j.idc.2005.03.007_bib33","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2005.03.007_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","article-title":"Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine","volume":"93","author":"Harro","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.idc.2005.03.007_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/376505","article-title":"Cellular immune response to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles","volume":"188","author":"Pinto","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2005.03.007_bib36","first-page":"6A","article-title":"The Holy Grail: immune control of human herpes simplex virus infection and disease","volume":"8","author":"Cunningham","year":"2001","journal-title":"Herpes"},{"key":"10.1016\/j.idc.2005.03.007_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/clinids\/2.6.899","article-title":"Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis","volume":"2","author":"Vestergaard","year":"1980","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib38","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1126\/science.2983428","article-title":"Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D","volume":"227","author":"Berman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.idc.2005.03.007_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jmv.1890170103","article-title":"Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD","volume":"17","author":"Dix","year":"1985","journal-title":"J Med Virol"},{"key":"10.1016\/j.idc.2005.03.007_bib40","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/infdis\/155.5.914","article-title":"Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes","volume":"155","author":"Stanberry","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/374002","article-title":"Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs","volume":"187","author":"Bourne","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib42","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(94)92581-X","article-title":"Placebo-controlled trial of vaccination with glycoprotein D of herpes simplex virus type 2 immunotherapy of genital herpes","volume":"343","author":"Straus","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2005.03.007_bib43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/514103","article-title":"Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled trial","volume":"176","author":"Straus","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib44","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/170.5.1100","article-title":"Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1","volume":"170","author":"McLean","year":"1994","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2005.03.007_bib45","first-page":"161A","article-title":"Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines","volume":"11","author":"Stanberry","year":"2004","journal-title":"Herpes"},{"key":"10.1016\/j.idc.2005.03.007_bib46","first-page":"235","article-title":"A double-blind study of the efficacy and safety of the ICP10DPK vaccine against recurrent genital HSV-2 infections","volume":"70","author":"Casanova","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.idc.2005.03.007_bib47","unstructured":"PowderMed Ltd. PowderMed initiates a phase I clinical trial for a novel therapeutic herpes simplex type 2 (HSV2) DNA vaccine. Available at: http:\/\/www.powdermed.com\/. Accessed December 5, 2004."},{"key":"10.1016\/j.idc.2005.03.007_bib48","unstructured":"Antigenics Inc. Genital herpes (HSV-2) trial. Available at: http:\/\/www.antigenics.com\/trials\/open\/gh\/info_gh.html. Accessed December 5, 2004."},{"key":"10.1016\/j.idc.2005.03.007_bib49","first-page":"3177","article-title":"Preinfection prophylaxis with herpes simplex virus glycoprotein immunogens: Factors influencing efficacy","volume":"70","author":"Stanberry","year":"1989","journal-title":"J Med Virol"},{"key":"10.1016\/j.idc.2005.03.007_bib50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group","volume":"282","author":"Corey","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2005.03.007_bib51","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D-adjuvant vaccine to prevent genital herpes","volume":"347","author":"Stanberry","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2005.03.007_bib52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/313687","article-title":"Prospects for control of herpes simplex virus disease through immunization","volume":"30","author":"Stanberry","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib53","unstructured":"National Institute of Allergy and Infectious Diseases. Herpevac trial for women. Available at: http:\/\/www.niaid.nih.gov\/dmid\/stds\/herpevac\/default.htm. Accessed December 5, 2004."},{"key":"10.1016\/j.idc.2005.03.007_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/sti.2002.003848","article-title":"The potential epidemiological impact of a genital herpes vaccine for women","volume":"80","author":"Garnett","year":"2004","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.idc.2005.03.007_bib55","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.OLQ.0000130536.71812.E5","article-title":"Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners","volume":"31","author":"Mays","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"3\u20134","key":"10.1016\/j.idc.2005.03.007_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10647440400020661","article-title":"Gynecologists' attitudes regarding human papillomavirus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists","volume":"12","author":"Raley","year":"2004","journal-title":"Infect Dis Obstet Gynocol"},{"key":"10.1016\/j.idc.2005.03.007_bib57","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0277-9536(03)00335-6","article-title":"Parental perspectives on vaccinating children against sexually transmitted infections","volume":"58","author":"Mays","year":"2004","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.idc.2005.03.007_bib58","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1258\/095646203321605486","article-title":"Attitudes about human papillomavirus vaccine in young women","volume":"14","author":"Kahn","year":"2003","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.idc.2005.03.007_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archpedi.159.2.132","article-title":"Parental attitudes about sexually transmitted infection vaccination for their adolescent children","volume":"15","author":"Zimet","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.idc.2005.03.007_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archpedi.159.2.190","article-title":"Editorial response: parental acceptability of vaccines for sexually transmitted infections","volume":"159","author":"Rosenthal","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.idc.2005.03.007_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF03404397","article-title":"Vaccine coverage during a school-based hepatitis B immunization program","volume":"89","author":"Deeks","year":"1998","journal-title":"Can J Public Health"},{"key":"10.1016\/j.idc.2005.03.007_bib62","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/01.OLQ.0000078823.05041.9E","article-title":"Viral sexually transmitted disease vaccine acceptability among college students","volume":"30","author":"Boehner","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/07399330050082227","article-title":"Attitudes of adolescent\/young adult women toward human papillomavirus vaccination and clinical trials","volume":"21","author":"Hoover","year":"2000","journal-title":"Health Care Women Int"},{"key":"10.1016\/j.idc.2005.03.007_bib64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007435-199909000-00004","article-title":"College students' attitudes regarding vaccination to prevent genital herpes","volume":"26","author":"Rosenthal","year":"1999","journal-title":"Sex Trans Dis"},{"key":"10.1016\/j.idc.2005.03.007_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/152460900318957","article-title":"Acceptability of human papillomavirus immunization","volume":"9","author":"Zimet","year":"2000","journal-title":"J Womens Health Gend Based Med"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552005000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552005000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T21:29:22Z","timestamp":1586294962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552005000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0891552005000267"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2005.03.007","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}